WHAM was established in 2020 to build the economic case for investing in the health of women. We produce data-driven reports and convene leaders across research, industry, government, and business to accelerate sex-based innovation that improves health outcomes and drives economic growth.
Women drive the majority of healthcare decisions, yet women’s health remains significantly undercapitalized across research, product development, and investment. Major gaps persist despite clear scientific evidence and economic opportunity.
A series of widely cited reports that quantify the costs of underinvestment in women’s health and demonstrate the benefits of increased research, innovation, and investing in companies focused on the health of women. The WHAM Report serves as a foundational resource for institutions, industry leaders, and decision-makers.

Early-stage research grants pursuing innovative, sex-based research supporting breakthroughs at the point where future impact and value are created.
The WHAM Collaboratives were each created to address a key gap in the innovation pipeline—from discovery through development and deployment. Together, they form a fully integrated and high-performing ecosystem focused on diseases and conditions that disproportionately, differently, or exclusively affect women across the lifespan—aligning science, investment, and product innovation to transform health outcomes and unlock substantial economic returns.
As a nonprofit organization, WHAM serves as a connector and a catalyst—aligning credible data, expert leadership, and resources to accelerate lasting progress for the health of society.
Through donations, partnerships and direct actions, you can help make a difference in the lives of millions of women and their families.
Make a donation, join the community, or help us spread the word about WHAM and our work—every little bit helps, and we are deeply appreciative of your support.
Women are 51% of the population but receive only a fraction of biomedical research funding. Sex differences are still often ignored, even in diseases that hit women hardest. Advancing sex-based research closes that gap, sparks innovation, and delivers more precise care for everyone. Support the future of health—for women, and for all.
This will close in 0 seconds
Four out of five Americans with autoimmune disease are women—40 million lives impacted—yet the science hasn’t kept up. In 2019, only 7 % of the NIH’s rheumatoid arthritis budget focused on women. Dedicated funding can pinpoint why women are so vulnerable and drive better diagnostics, therapies, and quality of life. Fuel research that will change lives.
This will close in 0 seconds
Women make up two-thirds of Alzheimer’s cases and are twice as likely to suffer depression—yet we still don’t know why. Targeted, sex-specific studies can reveal the biological and clinical differences that unlock earlier diagnosis, smarter treatments, and healthier minds. Your gift drives that discovery.
This will close in 0 seconds
Most cancer studies still default to male models, overlooking critical sex differences in how cancers start, spread, and respond to therapy. Lung cancer now kills more women than breast, ovarian, and cervical cancers combined, and rates are soaring among young, non-smoking women. Boosting sex-based cancer research will reveal why—and lead to breakthroughs in screening, care, and survival. Help us accelerate that work.
This will close in 0 seconds
Heart disease is the No. 1 killer of women, but it remains underfunded, under-researched, and underdiagnosed. Nearly half of women over 20 have cardiovascular disease, pregnancy heart risks are widespread, and women are 50% more likely to die after a heart attack. Focused research can rewrite those odds—changing how heart disease is detected, treated, and prevented in women. Invest in saving women’s hearts.
This will close in 0 seconds